Intraarticular corticosteroids in refractory childhood Lyme arthritis

Rheumatology International

Volumn 34, Issue 7, 2014, Pages 987-994

  Nimmrich, S ^a   Becker, I ^b   Horneff, G ^a  

^a Centre of Paediatric Rheumatology Department of General Paediatrics Asklepios Clinic Sankt Augustin   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Borreliosis; Intraarticular corticosteroids; Lyme arthritis

Indexed keywords

AMOXICILLIN; ANTIRHEUMATIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CORTICOSTEROID; DOXYCYCLINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; TRIAMCINOLONE HEXACETONIDE; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ANKLE; ANTIBIOTIC THERAPY; ANTIBODY PRODUCTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINGER JOINT; HIP; HUMAN; INJECTION; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE COUNT; LYME DISEASE; MALE; MONARTHRITIS; OUTCOME ASSESSMENT; PILOT STUDY; POLYARTHRITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SHOULDER; SYNOVIAL FLUID; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; BLOOD; DRUG COMBINATION; FOLLOW UP; IMMUNOLOGY; INTRAARTICULAR DRUG ADMINISTRATION; PRESCHOOL CHILD;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRA-ARTICULAR; LYME DISEASE; MALE; TRIAMCINOLONE ACETONIDE;

EID: 84903312498     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2923-9     Document Type: Article

References (41)

1. Nau R, Christen HJ et al (2009) Lyme disease-current state of knowledge. Dtsch Arztebl Int 106(5):72-81 quiz 82, I
2. Baranton G, Postic D et al (1992) Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42(3):378-383
3. Steere AC, Levin RE et al (1994) Treatment of Lyme arthritis. Arthritis Rheum 37(6):878-888
4. Bentas W, Karch H et al (2000) Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol 27(8):2025-2030
5. Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA (1999) Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 18(10):697-703 (Pubitemid 29537447)
6. Tory HO, Zurakowski D, Sundel RP (2010) Outcomes of children treated for Lyme arthritis: results of a large pediatric cohort. J Rheumatol 37(5):1049-1055
7. Huppertz HI, Bentas W, Haubitz I, Girschick HJ, Ganser G, Thon A, Suschke HJ, Schauer-Petrowskaja C, Minden K, Schuchmann L (1998) Diagnosis of paediatric Lyme arthritis using a clinical score. Eur J Pediatr 157(4):304-308 (Pubitemid 28178132)
8. Brescia AC, Rose CD et al (2009) Prolonged synovitis in pediatric Lyme arthritis cannot be predicted by clinical or laboratory parameters. Clin Rheumatol 28(5):591-593
9. Klempner MS, Hu LT et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345(2):85-92 (Pubitemid 32634566)
10. Oksi J, Nikoskelainen J et al (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26(8):571-581 (Pubitemid 47106811)
11. Dattwyler RJ, Halperin JJ et al (1988) Treatment of late Lyme borreliosis: randomised comparison of ceftriaxone and penicillin. Lancet 1(1988):1191-1194
12. Gasser R, Reisinger E, Eber B, Pokan R, Seinkost G, Berglöff J, Horwarth R, Se-Daj B (1995) Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific betalactamase inhibition. Microb Drug Resist 1:341-344
13. Preac-Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J (1989) Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17:355-359 (Pubitemid 20013457)
14. Krupp LB, Hyman LG et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60(12):1923-1930 (Pubitemid 36736007)
15. Wormser GP, Dattwyler RJ et al (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43(9):1089-1134 (Pubitemid 44637131)
16. DGPI Handbuch: Infektionen bei Kindern und Jugendlichen, 4. erweiterte und neu bearbeitete Auflage mit 984 Seiten, Hardcover, Futuramed Verlag, München ISBN 3-923599-90-0
17. Fallon BA, Keilp JG et al (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70(13):992-1003
18. O'Connell S (2010) Lyme borreliosis: current issues in diagnosis and management. Curr Opin Infect Dis 23(3):231-235
19. Puéchal X (2007) Non antibiotic treatments of Lyme borreliosis. Med Mal Infect 37(7-8):473-478
20. Cimmino M, Moggiana G et al (1996) Treatment of Lyme arthritis, Dipartimento di Medicina Interna, Università di Genova, Italy. Infection 24(1):91-93
21. Steere AC, Angelis SM (2006) Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 54(10):3079-3086 (Pubitemid 44622076)
22. Ogrinc K, Logar M et al (2006) Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis. Wien Klin Wochenschr 118(21-22):696-701 (Pubitemid 44953974)
23. Zulian F, Martini G et al (2004) Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford) 43(10):1288-1291
24. Steere AC, Duray PH et al (1988) Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum 31(4):487-495
25. Cameron D, Gaito A et al (2004) Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2(1 Suppl):S1-S13
26. Pavia C, Inchiosa MA Jr et al (2002) Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice. Antimicrob Agents Chemother 46(1):132-134 (Pubitemid 34031614)
27. Akin E, McHugh G et al (1999) The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis". Infect Immun 67(1):173-181 (Pubitemid 29021645)
28. Kalish R, Leong J et al (1993) Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi". Infect Immun 61(7):2774-2779 (Pubitemid 23182268)
29. Panelius J, Seppala I et al (1999) Evaluation of treatment responses in late Lyme borreliosis on the basis of antibody decrease during the follow-up period. Eur J Clin Microbiol Infect Dis 18(9):621-629
30. Chandra A, Wormser GP et al (2011) Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol 18(5): 767-771
31. Eberhard BA, Laxer RM et al (1994) Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol 96(2):260-266
32. Snydman DR, Schenkein DP, Berardi VP, Lastavica CC, Pariser KM (1986) Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 104(6):798-800 (Pubitemid 16115045)
33. Nocton J, Dressler F et al (1994) Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. J Engl J Med 330(4):229-234 (Pubitemid 24034134)
34. Hulinska D, Votypka J et al (1999) Persistence of Borrelia garinii and Borrelia afzelii in patients with Lyme arthritis. Zentralbl Bakteriol 289(3):301-318 (Pubitemid 29375139)
35. Steere AC, Schoen RT et al (1987) The clinical evolution of Lyme arthritis. Ann Intern Med 107(5):725-731 (Pubitemid 18041872)
36. Malawista SE (2000) Opinion:: Resolution of lyme arthritis, acute or prolonged: a new look. Inflammation 24(6):493-504
37. Feder HM Jr, Johnson BJ et al (2007) A critical appraisal of "chronic Lyme disease". N Engl J Med 357(14):1422-1430
38. Lunemann JD, Gelderblom H et al (2007) Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysineenriched protein domains and central nervous system autoantigens in early Lyme encephalitis. Infect Immun 75(1):243-251
39. Steere AC, Dwyer E et al (1990) Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 323(4):219-223
40. Klempner MS (2002) Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis 2(4):255-263
41. Carlson D, Hernandez J et al (1999) Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 42(12):2705-2709 (Pubitemid 30327194)